CN105055903A - Traditional Chinese medicine composition for treating lung cancer - Google Patents
Traditional Chinese medicine composition for treating lung cancer Download PDFInfo
- Publication number
- CN105055903A CN105055903A CN201510507449.1A CN201510507449A CN105055903A CN 105055903 A CN105055903 A CN 105055903A CN 201510507449 A CN201510507449 A CN 201510507449A CN 105055903 A CN105055903 A CN 105055903A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine composition for treating lung cancer. The traditional Chinese medicine composition comprises the following substances in parts by weight: 20-30 parts of marsdenia tenacissima, 5-10 parts of ganoderma lucidum, 25-35 parts of sinomenium acutum, 15-20 parts of scutellaria baicalensis, 12-16 parts of pericarpium citri reticulatae, 20-30 parts of poria cocos, 15-25 parts of pinellia ternata, 4-8 parts of licorice, 10-15 parts of pericarpium trichosanthis, 20-30 parts of asparagus cochinchinensis, 10-15 parts of radix trichosanthis, 20-30 parts of sagittaria trifolia var.sinensis, 20-30 parts of uncaria rhynchophylla, 5-10 parts of redflower gentian herb, 5-10 parts of wahlenbergia marginata, 20-30 parts of phyllanthus emblica, 10-15 parts of climbing violet herb, 20-30 parts of radix ginseng, 10-15 parts of dendrobium officinale, 15-20 parts of gynostemma pentaphyllum, 5-10 parts of rhodobryum roseum, 10-15 parts of bletilla striata, 15-25 parts of radix aucklandiae, 5-10 parts of fritillaria, 20-25 parts of rhizoma polygonati, 15-20 parts of telosma cordata, 5-10 parts of sculellaria barbata, 5-10 parts of polygonum bistorta, 5-10 parts of hedyotis diffusa, 10-15 parts of airpotato yam rhizome and 10-15 parts of fruits of fortune windmillpalm. The traditional Chinese medicine composition provided by the invention has the efficacies of clearing away heat and toxic materials, moistening lung, descending qi, invigorating spleen, reducing phlegm, deswelling and removing stasis, adopts the natural traditional Chinese medicine raw materials, has wide medicinal raw material sources, and is low in cost, simple in preparation, little in toxic and side effect and remarkable in curative effect.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of pulmonary carcinoma.
Background technology
Pulmonary carcinoma is one of malignant tumor that China's sickness rate is the highest, has been middle and advanced stage when making a definite diagnosis mostly, treats very difficult.Modern medicine emphasizes the Comprehensive Treatment to cancer, along with the development of radiotherapy technology, the continuous discovery of antineoplastic chemotherapy medicine, and the clinical practice of target therapeutic agent, the treatment level of pulmonary carcinoma obtains raising to a certain extent, but general curative effect is still unsatisfactory, can say that the therapeutic effect of pulmonary carcinoma is own through stepping into plateau.A large amount of clinical researches finds, the quality of life that Treatment of Lung Cancer with Chinese Medicine can be stablized focus, improve clinical symptoms, improves patient, makes the life span extension of patient.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of pulmonary carcinoma.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of pulmonary carcinoma, it comprises the material of following weight portion: TONGGUAN FEN 20-30 part, Ganoderma 5-10 part, Sinomenium acutum 25-35 part, Radix Scutellariae 15-20 part, Pericarpium Citri Reticulatae 12-16 part, Poria 20-30 part, Rhizoma Pinelliae 15-25 part, Radix Glycyrrhizae 4-8 part, Pericarpium Trichosanthis 10-15 part, Radix Asparagi 20-30 part, Radix Trichosanthis 10-15 part, Herba Passiflorae Cupiformis 20-30 part, Ramulus Uncariae Cum Uncis 20-30 part, Gentiana rhodantha Franch. 5-10 part, Herba Wahlenbergiae 5-10 part, Phyllanthus emblica L. 20-30 part, Herba Violae diffusae 10-15 part, Radix Ginseng 20-30 part, Herba Dendrobii 10-15 part, Herb Gynostemmae Pentaphylli 15-20 part, Rhodobryum roseum Limpr. 5-10 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-15 part, Radix Aucklandiae 15-25 part, Bulbus Fritillariae Uninbracteatae 5-10 part, Rhizoma Polygonati 20-25 part, night fragrant flower 15-20 part, Herba Scutellariae Barbatae 5-10 part, Rhizoma Bistortae 5-10 part, Herba Hedyotidis Diffusae 5-10 part, Rhizoma Dioscoreae Bulbiferae 10-15 part and Fructus trachycarpi 10-15 part.
Preferably, the Chinese medicine composition for the treatment of pulmonary carcinoma of the present invention comprises the material of following weight portion: TONGGUAN FEN 24 parts, Ganoderma 8 parts, Sinomenium acutum 30 parts, Radix Scutellariae 18 parts, Pericarpium Citri Reticulatae 15 parts, 25 parts, Poria, the Rhizoma Pinelliae 20 parts, 5 parts, Radix Glycyrrhizae, Pericarpium Trichosanthis 12 parts, Radix Asparagi 25 parts, Radix Trichosanthis 12 parts, Herba Passiflorae Cupiformis 25 parts, Ramulus Uncariae Cum Uncis 25 parts, Gentiana rhodantha Franch. 8 parts, Herba Wahlenbergiae 8 parts, Phyllanthus emblica L. 25 parts, Herba Violae diffusae 12 parts, Radix Ginseng 25 parts, Herba Dendrobii 12 parts, Herb Gynostemmae Pentaphylli 18 parts, Rhodobryum roseum Limpr. 8 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 12 parts, the Radix Aucklandiae 20 parts, Bulbus Fritillariae Uninbracteatae 8 parts, Rhizoma Polygonati 22 parts, night 18 parts, fragrant flower, Herba Scutellariae Barbatae 8 parts, Rhizoma Bistortae 8 parts, Herba Hedyotidis Diffusae 8 parts, Rhizoma Dioscoreae Bulbiferae 12 parts and Fructus trachycarpi 12 parts.
More preferably, the Chinese medicine composition for the treatment of pulmonary carcinoma of the present invention also comprises the material of following weight portion: Herba Bidentis Bipinnatae 18 parts, Fructus Tsaoko 15 parts, Changuienia amoena Chien 12 parts, Fructus psidii guajavae immaturus root 10 parts, Herba Blumeae lanceolariae 12 parts, Iris speculatrix Hance 15 parts, Fructus Styracis obassiae 13 parts, Semen Ciceris Arietini 8 parts, Semen Sojae Preparatum 79 parts, auspicious even grass 12 parts, Radix Rubi Parvifolii 9 parts, Rhizoma Amorphophalli virosi 8 parts, Bermuda grass 9 parts, province 10 parts, rattan, Herba Clematidis tanguticae 7 parts and Herba Goodyerae Procerae 8 parts.
Most preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, pill or decoction.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment pulmonary carcinoma, described compositions comprises the material of following weight portion: TONGGUAN FEN 20-30 part, Ganoderma 5-10 part, Sinomenium acutum 25-35 part, Radix Scutellariae 15-20 part, Pericarpium Citri Reticulatae 12-16 part, Poria 20-30 part, Rhizoma Pinelliae 15-25 part, Radix Glycyrrhizae 4-8 part, Pericarpium Trichosanthis 10-15 part, Radix Asparagi 20-30 part, Radix Trichosanthis 10-15 part, Herba Passiflorae Cupiformis 20-30 part, Ramulus Uncariae Cum Uncis 20-30 part, Gentiana rhodantha Franch. 5-10 part, Herba Wahlenbergiae 5-10 part, Phyllanthus emblica L. 20-30 part, Herba Violae diffusae 10-15 part, Radix Ginseng 20-30 part, Herba Dendrobii 10-15 part, Herb Gynostemmae Pentaphylli 15-20 part, Rhodobryum roseum Limpr. 5-10 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-15 part, Radix Aucklandiae 15-25 part, Bulbus Fritillariae Uninbracteatae 5-10 part, Rhizoma Polygonati 20-25 part, night fragrant flower 15-20 part, Herba Scutellariae Barbatae 5-10 part, Rhizoma Bistortae 5-10 part, Herba Hedyotidis Diffusae 5-10 part, Rhizoma Dioscoreae Bulbiferae 10-15 part and Fructus trachycarpi 10-15 part.
Preferably, described compositions comprises the material of following weight portion: TONGGUAN FEN 24 parts, Ganoderma 8 parts, Sinomenium acutum 30 parts, Radix Scutellariae 18 parts, Pericarpium Citri Reticulatae 15 parts, 25 parts, Poria, the Rhizoma Pinelliae 20 parts, 5 parts, Radix Glycyrrhizae, Pericarpium Trichosanthis 12 parts, Radix Asparagi 25 parts, Radix Trichosanthis 12 parts, Herba Passiflorae Cupiformis 25 parts, Ramulus Uncariae Cum Uncis 25 parts, Gentiana rhodantha Franch. 8 parts, Herba Wahlenbergiae 8 parts, Phyllanthus emblica L. 25 parts, Herba Violae diffusae 12 parts, Radix Ginseng 25 parts, Herba Dendrobii 12 parts, Herb Gynostemmae Pentaphylli 18 parts, Rhodobryum roseum Limpr. 8 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 12 parts, the Radix Aucklandiae 20 parts, Bulbus Fritillariae Uninbracteatae 8 parts, Rhizoma Polygonati 22 parts, night 18 parts, fragrant flower, Herba Scutellariae Barbatae 8 parts, Rhizoma Bistortae 8 parts, Herba Hedyotidis Diffusae 8 parts, Rhizoma Dioscoreae Bulbiferae 12 parts and Fructus trachycarpi 12 parts.
More preferably, described compositions also comprises the material of following weight portion: Herba Bidentis Bipinnatae 18 parts, Fructus Tsaoko 15 parts, Changuienia amoena Chien 12 parts, Fructus psidii guajavae immaturus root 10 parts, Herba Blumeae lanceolariae 12 parts, Iris speculatrix Hance 15 parts, Fructus Styracis obassiae 13 parts, Semen Ciceris Arietini 8 parts, Semen Sojae Preparatum 79 parts, auspicious even grass 12 parts, Radix Rubi Parvifolii 9 parts, Rhizoma Amorphophalli virosi 8 parts, Bermuda grass 9 parts, province 10 parts, rattan, Herba Clematidis tanguticae 7 parts and Herba Goodyerae Procerae 8 parts.
Most preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, pill or decoction.
In the present invention, TONGGUAN FEN is mixed by the powder of Fructus Gleditsiae Abnormalis, Herba Centipedae, Herba Asari three kinds of medical materials, and wherein the weight of three taste medical materials is identical.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 decoction of the present invention
Take TONGGUAN FEN 24 grams, Ganoderma 8 grams, Sinomenium acutum 30 grams, Radix Scutellariae 18 grams, Pericarpium Citri Reticulatae 15 grams, 25 grams, Poria, the Rhizoma Pinelliae 20 grams, 5 grams, Radix Glycyrrhizae, Pericarpium Trichosanthis 12 grams, Radix Asparagi 25 grams, Radix Trichosanthis 12 grams, Herba Passiflorae Cupiformis 25 grams, Ramulus Uncariae Cum Uncis 25 grams, Gentiana rhodantha Franch. 8 grams, Herba Wahlenbergiae 8 grams, Phyllanthus emblica L. 25 grams, Herba Violae diffusae 12 grams, Radix Ginseng 25 grams, Herba Dendrobii 12 grams, Herb Gynostemmae Pentaphylli 18 grams, Rhodobryum roseum Limpr. 8 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 12 grams, the Radix Aucklandiae 20 grams, Bulbus Fritillariae Uninbracteatae 8 grams, Rhizoma Polygonati 22 grams, night 18 grams, fragrant flower, Herba Scutellariae Barbatae 8 grams, Rhizoma Bistortae 8 grams, Herba Hedyotidis Diffusae 8 grams, Rhizoma Dioscoreae Bulbiferae 12 grams and Fructus trachycarpi 12 grams, pulverize, cross 20 mesh sieves, add 6000 milliliters, water, heating 3 hours under the condition of backflow, filter, filtrate is made to be cooled to room temperature, be described decoction.
Embodiment 2 decoction of the present invention
Take TONGGUAN FEN 24 grams, Ganoderma 8 grams, Sinomenium acutum 30 grams, Radix Scutellariae 18 grams, Pericarpium Citri Reticulatae 15 grams, 25 grams, Poria, the Rhizoma Pinelliae 20 grams, 5 grams, Radix Glycyrrhizae, Pericarpium Trichosanthis 12 grams, Radix Asparagi 25 grams, Radix Trichosanthis 12 grams, Herba Passiflorae Cupiformis 25 grams, Ramulus Uncariae Cum Uncis 25 grams, Gentiana rhodantha Franch. 8 grams, Herba Wahlenbergiae 8 grams, Phyllanthus emblica L. 25 grams, Herba Violae diffusae 12 grams, Radix Ginseng 25 grams, Herba Dendrobii 12 grams, Herb Gynostemmae Pentaphylli 18 grams, Rhodobryum roseum Limpr. 8 grams, the Pseudobulbus Bletillae (Rhizoma Bletillae) 12 grams, the Radix Aucklandiae 20 grams, Bulbus Fritillariae Uninbracteatae 8 grams, Rhizoma Polygonati 22 grams, night 18 grams, fragrant flower, Herba Scutellariae Barbatae 8 grams, Rhizoma Bistortae 8 grams, Herba Hedyotidis Diffusae 8 grams, Rhizoma Dioscoreae Bulbiferae 12 grams, Fructus trachycarpi 12 grams, Herba Bidentis Bipinnatae 18 grams, Fructus Tsaoko 15 grams, Changuienia amoena Chien 12 grams, Fructus psidii guajavae immaturus root 10 grams, Herba Blumeae lanceolariae 12 grams, Iris speculatrix Hance 15 grams, Fructus Styracis obassiae 13 grams, Semen Ciceris Arietini 8 grams, Semen Sojae Preparatum 79 grams, auspicious even grass 12 grams, Radix Rubi Parvifolii 9 grams, Rhizoma Amorphophalli virosi 8 grams, Bermuda grass 9 grams, economize 10 grams, rattan, Herba Clematidis tanguticae 7 grams and Herba Goodyerae Procerae 8 grams, pulverize, and crosses 20 mesh sieves, add 6000 milliliters, water, and under the condition of backflow, heating 3 hours, filters, make filtrate be cooled to room temperature, be described decoction.
Experimental example
According to clinical symptoms, sign and imaging examination, the one meeting following situations can be used as clinical diagnosis:
1, chest X-ray finds Pulmonary Isolated Nodules or swollen thing, jagged;
2, pulmonary high-risk group, has cough or bloody sputum, and chest X-ray finds Focal lesion, through positive antiinflammatory or antituberculosis therapy (2 weeks-4 weeks) invalid or pathological changes increase person;
3, segmental pneumonia developed into segmental atelectasis in 2 months-3 months, or segmental atelectasis develops into full pulmonary atelectasis in a short time;
4, occur the side growth property bloody pleural fluid without other reasons in a short time, or side volume bloody pleural fluid accompanies pulmonary atelectasis person or pleural nodulations shape changer simultaneously;
5, obviously cough, out of breath, the two lung millet appearance of chest films showed or diffuse lesion, can get rid of Military tuberculosis, pulmonary metastases, pulmonary mycosis person;
6, rabat finds pulmonary lump, with hilus pulumonis or vertical phrenic lymph nodes enlargement, and occurs that superior vena cava blocks, recurrent nerve paralysis symptom, or with metastasis shower.
7, cough but no phlegm or few expectorant, or sputum mixed with blood, very then spit blood more than, chest pain, vexed difference of sleeping, low grade fever night sweat, or the strong Sheng of calorific potential, checks for a long time and do not move back, thirsty, constipation with dry stool, red tongue, and yellow fur, thready and rapid pulse or number are greatly.
Selector close standard of stating patient 100 example, wherein man 50 example, female 50 example, patient age 41-65 year, the mean age be (48.5 ± 4.5) year, be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 50 routine patients.Two groups of Genders, age, the course of disease, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the decoction of preparation in embodiment 1 to treat, every day twice, oral 500 milliliters at every turn, continuously treatment 3 months.
Treatment group 2 uses the pill of preparation in embodiment 2 to treat, every day twice, oral 500 milliliters at every turn, continuously treatment 3 months.
According to Short-term, appraisal of life quality 2 indexs, observe therapeutic effect.
1. Short-term criterion of therapeutical effect: according to the objective efficacy assessment standard of WHO treatment of cancer (Chinese Anti-Cancer Association. newly organized common pernicious pulmonary carcinoma diagnosis and treatment specification primary bronchogenic carcinoma of lung fascicle [S]. Beijing: combined publication society of China Concord Medical Science University of Beijing Medical University .1999:14-26.541.), different by treatment pulmonary carcinoma size variation, curative effect is divided into 4 grades.1. complete incidence graph: pulmonary carcinoma focus disappears completely and at least maintains more than 4 weeks; 2. partial rcsponse: the maximum gauge of pulmonary carcinoma focus and the product of maximum perpendicular transverse diameter reduce >=and 50%, and maintain more than 4 weeks, occur without new focus; 3. stablize: two footpath products of swollen lame focus reduce < 50%, increase < 25%, maintain more than 4 weeks, occur without new focus; 4. progress is worsened: pulmonary carcinoma increases >=25% or occur new focus.
2. appraisal of life quality: by Ka Shi standards of grading (look into people person of outstanding talent. modern pulmonary cancer diagnosis and treatment (M) .2 version. Beijing: People's Medical Officer Press .1999:416), after treatment, rising 10 is divided into effectively, it is invalid that decline 10 is divided into, and it is stable for being elevated between 10 points.
Statistical method
Utilize SPSS13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation
represent, adopt t inspection, enumeration data adopts χ
2inspection, P < 0.05 represents that difference has statistical significance.
Therapeutic outcome
1. Short-term
For treatment group 1, complete incidence graph 16 example, partial rcsponse 18 example, stablizes 8 examples, and worsen progress 8 example, total effective rate is 84%; For treatment group 2, complete incidence graph 18 example, partial rcsponse 19 example, stablizes 10 examples, and worsen progress 3 example, total effective rate is 94%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).The effect for the treatment of group 2 is better than the effect for the treatment of group 1.
2. Ka Shi scoring after quality of life treatment
For treatment group 1, effective 34 examples of therapeutic effect, therapeutic effect stablizes 8 examples, invalid 8 examples of therapeutic effect, and total effective rate is 84%; For treatment group 2, effective 37 examples of therapeutic effect, therapeutic effect stablizes 10 examples, and invalid 3 examples of therapeutic effect, total effective rate is 94%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).The effect for the treatment of group 2 is better than the effect for the treatment of group 1.
Untoward reaction and toxic and side effects supervision
By detect patient blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Find that the systolic pressure of all patients is between 90-140mmHg, diastolic pressure is between 60-90mmHg, and pulse is 60-100 beat/min, and blood pressure and pulse all within normal range, and does not occur Nausea and vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that medicine does not have obvious toxic and side effects for human body.
Claims (8)
1. treat the Chinese medicine composition of pulmonary carcinoma for one kind, it is characterized in that, it comprises the material of following weight portion: TONGGUAN FEN 20-30 part, Ganoderma 5-10 part, Sinomenium acutum 25-35 part, Radix Scutellariae 15-20 part, Pericarpium Citri Reticulatae 12-16 part, Poria 20-30 part, Rhizoma Pinelliae 15-25 part, Radix Glycyrrhizae 4-8 part, Pericarpium Trichosanthis 10-15 part, Radix Asparagi 20-30 part, Radix Trichosanthis 10-15 part, Herba Passiflorae Cupiformis 20-30 part, Ramulus Uncariae Cum Uncis 20-30 part, Gentiana rhodantha Franch. 5-10 part, Herba Wahlenbergiae 5-10 part, She sweet fruit 20-30 part, Herba Violae diffusae 10-15 part, Radix Ginseng 20-30 part, Herba Dendrobii 10-15 part, Herb Gynostemmae Pentaphylli 15-20 part, Rhodobryum roseum Limpr. 5-10 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-15 part, Radix Aucklandiae 15-25 part, Bulbus Fritillariae Uninbracteatae 5-10 part, Rhizoma Polygonati 20-25 part, night fragrant flower 15-20 part, Herba Scutellariae Barbatae 5-10 part, Rhizoma Bistortae 5-10 part, Herba Hedyotidis Diffusae 5-10 part, Rhizoma Dioscoreae Bulbiferae 10-15 part and Fructus trachycarpi 10-15 part.
2. the Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1, it is characterized in that, it comprises the material of following weight portion: TONGGUAN FEN 24 parts, Ganoderma 8 parts, Sinomenium acutum 30 parts, Radix Scutellariae 18 parts, Pericarpium Citri Reticulatae 15 parts, 25 parts, Poria, the Rhizoma Pinelliae 20 parts, 5 parts, Radix Glycyrrhizae, Pericarpium Trichosanthis 12 parts, Radix Asparagi 25 parts, Radix Trichosanthis 12 parts, Herba Passiflorae Cupiformis 25 parts, Ramulus Uncariae Cum Uncis 25 parts, Gentiana rhodantha Franch. 8 parts, Herba Wahlenbergiae 8 parts, the sweet fruit of She 25 parts, Herba Violae diffusae 12 parts, Radix Ginseng 25 parts, Herba Dendrobii 12 parts, Herb Gynostemmae Pentaphylli 18 parts, Rhodobryum roseum Limpr. 8 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 12 parts, the Radix Aucklandiae 20 parts, Bulbus Fritillariae Uninbracteatae 8 parts, Rhizoma Polygonati 22 parts, night 18 parts, fragrant flower, Herba Scutellariae Barbatae 8 parts, Rhizoma Bistortae 8 parts, Herba Hedyotidis Diffusae 8 parts, Rhizoma Dioscoreae Bulbiferae 12 parts and Fructus trachycarpi 12 parts.
3. the Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: Herba Bidentis Bipinnatae 18 parts, Fructus Tsaoko 15 parts, Changuienia amoena Chien 12 parts, Fructus psidii guajavae immaturus root 10 parts, Herba Blumeae lanceolariae 12 parts, Iris speculatrix Hance 15 parts, Fructus Styracis obassiae 13 parts, Semen Ciceris Arietini 8 parts, Semen Sojae Preparatum 79 parts, auspicious even grass 12 parts, Radix Rubi Parvifolii 9 parts, Rhizoma Amorphophalli virosi 8 parts, Bermuda grass 9 parts, province 10 parts, rattan, Herba Clematidis tanguticae 7 parts and Herba Goodyerae Procerae 8 parts.
4. the Chinese medicine composition for the treatment of pulmonary carcinoma according to claim 3, is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, pill or decoction.
5. the purposes of compositions in the Chinese medicine of preparation treatment pulmonary carcinoma, it is characterized in that, described compositions comprises the material of following weight portion: TONGGUAN FEN 20-30 part, Ganoderma 5-10 part, Sinomenium acutum 25-35 part, Radix Scutellariae 15-20 part, Pericarpium Citri Reticulatae 12-16 part, Poria 20-30 part, Rhizoma Pinelliae 15-25 part, Radix Glycyrrhizae 4-8 part, Pericarpium Trichosanthis 10-15 part, Radix Asparagi 20-30 part, Radix Trichosanthis 10-15 part, Herba Passiflorae Cupiformis 20-30 part, Ramulus Uncariae Cum Uncis 20-30 part, Gentiana rhodantha Franch. 5-10 part, Herba Wahlenbergiae 5-10 part, She sweet fruit 20-30 part, Herba Violae diffusae 10-15 part, Radix Ginseng 20-30 part, Herba Dendrobii 10-15 part, Herb Gynostemmae Pentaphylli 15-20 part, Rhodobryum roseum Limpr. 5-10 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 10-15 part, Radix Aucklandiae 15-25 part, Bulbus Fritillariae Uninbracteatae 5-10 part, Rhizoma Polygonati 20-25 part, night fragrant flower 15-20 part, Herba Scutellariae Barbatae 5-10 part, Rhizoma Bistortae 5-10 part, Herba Hedyotidis Diffusae 5-10 part, Rhizoma Dioscoreae Bulbiferae 10-15 part and Fructus trachycarpi 10-15 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: TONGGUAN FEN 24 parts, Ganoderma 8 parts, Sinomenium acutum 30 parts, Radix Scutellariae 18 parts, Pericarpium Citri Reticulatae 15 parts, 25 parts, Poria, the Rhizoma Pinelliae 20 parts, 5 parts, Radix Glycyrrhizae, Pericarpium Trichosanthis 12 parts, Radix Asparagi 25 parts, Radix Trichosanthis 12 parts, Herba Passiflorae Cupiformis 25 parts, Ramulus Uncariae Cum Uncis 25 parts, Gentiana rhodantha Franch. 8 parts, Herba Wahlenbergiae 8 parts, the sweet fruit of She 25 parts, Herba Violae diffusae 12 parts, Radix Ginseng 25 parts, Herba Dendrobii 12 parts, Herb Gynostemmae Pentaphylli 18 parts, Rhodobryum roseum Limpr. 8 parts, the Pseudobulbus Bletillae (Rhizoma Bletillae) 12 parts, the Radix Aucklandiae 20 parts, Bulbus Fritillariae Uninbracteatae 8 parts, Rhizoma Polygonati 22 parts, night 18 parts, fragrant flower, Herba Scutellariae Barbatae 8 parts, Rhizoma Bistortae 8 parts, Herba Hedyotidis Diffusae 8 parts, Rhizoma Dioscoreae Bulbiferae 12 parts and Fructus trachycarpi 12 parts.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: Herba Bidentis Bipinnatae 18 parts, Fructus Tsaoko 15 parts, Changuienia amoena Chien 12 parts, Fructus psidii guajavae immaturus root 10 parts, Herba Blumeae lanceolariae 12 parts, Iris speculatrix Hance 15 parts, Fructus Styracis obassiae 13 parts, Semen Ciceris Arietini 8 parts, Semen Sojae Preparatum 79 parts, auspicious even grass 12 parts, Radix Rubi Parvifolii 9 parts, Rhizoma Amorphophalli virosi 8 parts, Bermuda grass 9 parts, province 10 parts, rattan, Herba Clematidis tanguticae 7 parts and Herba Goodyerae Procerae 8 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, pill or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510507449.1A CN105055903A (en) | 2015-08-18 | 2015-08-18 | Traditional Chinese medicine composition for treating lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510507449.1A CN105055903A (en) | 2015-08-18 | 2015-08-18 | Traditional Chinese medicine composition for treating lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105055903A true CN105055903A (en) | 2015-11-18 |
Family
ID=54485580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510507449.1A Pending CN105055903A (en) | 2015-08-18 | 2015-08-18 | Traditional Chinese medicine composition for treating lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105055903A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105597027A (en) * | 2016-03-04 | 2016-05-25 | 陈海林 | Traditional Chinese medicine composition for treating lung cancer |
| CN105663944A (en) * | 2016-01-22 | 2016-06-15 | 高淑萍 | Medicine combination for treating lung cancer |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241438A (en) * | 1999-06-23 | 2000-01-19 | 陈大明 | Lung cancer treating Chinese medicine preparation and its preparation |
| CN103028077A (en) * | 2012-12-24 | 2013-04-10 | 秦旭东 | Traditional Chinese medicine preparation for treating tumors |
| CN104383390A (en) * | 2014-10-30 | 2015-03-04 | 宿州学院 | Chinese traditional medicine preparation for treating lung cancer |
-
2015
- 2015-08-18 CN CN201510507449.1A patent/CN105055903A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241438A (en) * | 1999-06-23 | 2000-01-19 | 陈大明 | Lung cancer treating Chinese medicine preparation and its preparation |
| CN103028077A (en) * | 2012-12-24 | 2013-04-10 | 秦旭东 | Traditional Chinese medicine preparation for treating tumors |
| CN104383390A (en) * | 2014-10-30 | 2015-03-04 | 宿州学院 | Chinese traditional medicine preparation for treating lung cancer |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105663944A (en) * | 2016-01-22 | 2016-06-15 | 高淑萍 | Medicine combination for treating lung cancer |
| CN105597027A (en) * | 2016-03-04 | 2016-05-25 | 陈海林 | Traditional Chinese medicine composition for treating lung cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102366464B (en) | Antitumor traditional Chinese medicine composition | |
| CN103893722B (en) | A kind of Chinese medicine composition and its preparation method treating sunburn | |
| CN104547525A (en) | Drug composition for NSCLC (Non Small Cell Lung Cancer) prevention and preparation method thereof | |
| CN111529634A (en) | Qingyeyupingfeng powder medicine beverage and preparation method thereof | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN103961614B (en) | Chinese medicine composition for treating respiratory disease and its production and use | |
| CN105055903A (en) | Traditional Chinese medicine composition for treating lung cancer | |
| CN104621310A (en) | Health tea and application thereof | |
| CN102247479A (en) | Antitumor strong medicine and preparation method thereof | |
| CN103417911B (en) | Traditional Chinese medicine composition for supporting chemo-treatment | |
| CN104587267A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN108186794A (en) | A kind of Chinese medicine composition for treating malignant tumour and its preparation method and application | |
| CN103520697A (en) | Traditional Chinese medicine for treating qi-yin deficiency syndrome type chest stuffiness and pains | |
| CN106983816B (en) | Medicine for maintaining patients with sexual hemodialysis complicated with chronic heart failure and preparation method thereof | |
| CN105521246A (en) | Medicinal preparation for treating lung cancer and applications of medicinal preparation | |
| CN104189763A (en) | Traditional Chinese medicine composition for treating stomach cancer | |
| CN110934974A (en) | Traditional Chinese medicine composition for treating lung cancer, traditional Chinese medicine preparation and preparation method thereof | |
| CN104825609A (en) | Pharmaceutical composition for improving adverse effects of chemotherapeutic hyperthermic intraperitoneal perfusion and preparing method thereof | |
| CN104922528A (en) | Medicine composite for treating malignant pleural effusion and preparation method and purpose thereof | |
| CN104840773A (en) | Traditional Chinese medicine composition for treating vertebral artery type cervical spondylopathy and method for preparing same | |
| CN100363044C (en) | Medicine for treating acne and its preparation method | |
| CN104189770A (en) | Pharmaceutical composition for treating tuberculous pleuritis and preparation method thereof | |
| CN110101800A (en) | It is a kind of to treat malignant pleural effusion Chinese medicine composition and its application | |
| CN103735635A (en) | Medicinal composition for treating cancers and leukemia | |
| CN103055094B (en) | Traditional Chinese medicine for treating leukemia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151118 |
|
| RJ01 | Rejection of invention patent application after publication |